Biosimilar – Insulin
Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them.
Antibiotics
Antibiotics are medicines that fight bacterial infections in people. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply.
Injectables
Injected medicines are commonly used in healthcare settings for the prevention, diagnosis, and treatment of various illnesses.
IV Solutions
IV fluids are specially formulated liquids that are injected into a vein to prevent or treat dehydration. They are used in people of all ages who are sick, injured, dehydrated from exercise or heat, or undergoing surgery.
About Us
BIOPHARMAX AFEZCO located in the ALAT free economic zone in Azerbaijan. The company is an innovative high-tech biopharmaceutical enterprise committed to the introduction and absorption of international advanced biotechnology, and the development, production, and sales of bio-pharmaceutical products. BIOPHARMAX AFEZCO committed to Introduction and absorption of international advanced biotech technologies for local production as well as export of biopharmaceutical products. BIOPHARMAX AFEZCO will be the foundation of Azerbaijan to become self-sufficient of Biopharmaceutical production & Life Science HUB of the region.
For over 40 years Biopharmax has catered to industry leaders around the world and has gained unique capabilities in process engineering and technology transfer related projects.
Biopharmax provides Turnkey based solutions, having all end-to-end disciplines under one roof. Allowing a full range of services required to design and execute your new manufacturing facility, resulting in a time efficient, cost effective, tailor-made, highly optimized projects.
- End-to-end solution
- Expertise & Experience.
- On time & budget Quality & Reliability
Highest standards
Quality control
High Purity
Secure supply chain
Continuous availability
ScGMP production facility
Services
With decades of industry experience and hundreds of successful projects, Biopharmax positioned itself as one of the world leaders in design, construction and validation of biopharmaceutical facilitie
Products
More than half a billion people are living with diabetes worldwide, affecting men, women, and children of all ages in every country, and that number is projected to more than double to 1.3 billion people in the next 30 years. The latest and most comprehensive calculations show the current global prevalence rate is 6.1%, making diabetes one of the top 10 leading causes of death and disability.
BioAsulin Vial Wosulin R 3ml 5x3ml
Generic name Recombinant Human Insulin Injection Properties Colorless transparent liquid Specification 5 X 3 ml: 100 IU / ML Indication Medical treatment diabetic patients Administration Subcutaneous injection
BioAsulin Vial Wosulin R 3ml
Generic name Recombinant Human Insulin Injection Properties Colorless transparent liquid Specification 3 ml: 100 IU / ML Indication Treatment of Diabetes (Type 1 and 2) Administration Subcutaneous injection
BioAsulin Vial Wosulin Insulin Isophane/NPH 70%, 30% Human Insulin/Soluble Inj
Generic name Recombinant Human Insulin Injection Properties Colorless transparent liquid Specification 10ml: 100 IU / ML Indication Treatment of Diabetes (Type 1 and 2) Administration Subcutaneous injection
BioAsulin Wosulin DispoPen 5 pens
Generic name Recombinant Human Insulin Injection Properties Colorless transparent liquid Specification 5 x100 IU / ML Indication Treatment of Diabetes (Type 1 and 2) Administration Subcutaneous injection
BioAsulin Wosulin DispoPen 5 pens
Generic name Recombinant Human Insulin Injection Properties Colorless transparent liquid Specification 100 IU / ML Indication Treatment of Diabetes (Type 1 and 2) Administration Subcutaneous injectionNews
Opening a branch of BioPharmax on the territory of Alat Free Economic Zone (AFEZ) in Azerbaijan will allow to expand the company's presence in the region, CEO of BioPharmax Israeli company Sarel Chen-Tov said during the signing of an agreement with AFEZ
Medinex 2022
A meeting was held at the Ministry of Health of Azerbaijan with the management of BioPharmax, one of the leading companies in Israel for the production of medical products.
Vugar Gurbanov, executive director of the Medical Territorial Units Management Union (TABIB), met with Yossi Zabari, executive director of the Israeli pharmaceutical company "BioPharmax Afezco", which participated in the "Medinex" Azerbaijan International Medical Innovations exhibition..
A meeting was held with the management team of "BioPharmax", one of Israel's leading companies for the production of medical products, in the Association for the Management of Medical Territorial Units (TABIB).
We are pleased to invite you to visit our stand #M 232 at Medinex 2023-The 3rd Azerbaijan International Exhibition of Medical Innovations.The Exhibition will be held on November,2,3,4 at Baku Expo Center. This is the 2nd year Biopharmax AFEZCO is going to take a part at Medinex and present its products. We'll be happy to see you among our visitors.
